Liminatus Pharma, Inc.

Item 8.01 Other Events. As a result of the previously announced merger transaction with InnocsAI LLC, as of the date of this Current Report on Form 8-K, Liminatus Pharma, Inc. (the “Company”) believes it has stockholders’ equity in excess of $2.5 million. The Company is waiting for a compliance determination from The Nasdaq Stock Market LLC (“Nasdaq”). However, even if Nasdaq determines that the Company is in compliance with its rules, Nasdaq will continue to monitor the Company’s ongoing compliance with the stockholders’ equity requirement, and, if at the time of its next periodic report the Company does not evidence compliance, the Company may be subject to future delisting. Forward-Looking Statements Certain information contained in this report consists of forward-looking statements for purposes of the federal securities law that involve risks, uncertainties and assumptions that are difficult to predict. Words such as “will,” “would,” “may,” “intends,” “potential,” and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. For example, there can be no assurance that Nasdaq will accept the Company’s plan to regain compliance or that the Company will regain compliance with the Nasdaq listing rules during any compliance period or in the future, or otherwise meet Nasdaq continued listing standards. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company’s filings with the SEC. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.